{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:23:14Z","timestamp":1786119794588,"version":"build-2736575974"},"reference-count":32,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,7]]},"DOI":"10.1097\/iae.0b013e31820d4000","type":"journal-article","created":{"date-parts":[[2011,5,7]],"date-time":"2011-05-07T03:22:53Z","timestamp":1304738573000},"page":"1239-1247","source":"Crossref","is-referenced-by-count":26,"title":["INTRAVITREAL BEVACIZUMAB AS SUPPLEMENTAL TREATMENT OR MONOTHERAPY FOR SEVERE RETINOPATHY OF PREMATURITY"],"prefix":"10.1097","volume":"31","author":[{"given":"Ruth","family":"Axer-Siegel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moshe","family":"Snir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yonina","family":"Ron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronit","family":"Friling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lea","family":"Sirota","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dov","family":"Weinberger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-2-20210130","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1007\/BF01701481","article-title":"Retinopathy of prematurity.","volume":"21","author":"Bossi","year":"1995","journal-title":"Intensive Care Med"},{"key":"R2-2-20210130","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1001\/archopht.1996.01100140410008","article-title":"Correlation of vascular permeability factor\/vascular endothelial growth factor with extraretinal neovascularization in the rat.","volume":"114","author":"Dorey","year":"1996","journal-title":"Arch Ophthalmol"},{"key":"R3-2-20210130","first-page":"290","article-title":"Roles of endothelial growth factor and astrocyte degeneration in the genesis of retinopathy of prematurity.","volume":"37","author":"Stone","year":"1996","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R4-2-20210130","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1136\/bjo.2005.086330","article-title":"Diode laser versus cryotherapy in treatment of ROP [editorial].","volume":"90","author":"OKeefe","year":"2006","journal-title":"BJO"},{"key":"R5-2-20210130","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1097\/IAE.0b013e318169faee","article-title":"Diode laser treatment of retinopathy of prematurity: anatomic and refractive outcome.","volume":"28","author":"Axer-Siegel","year":"2008","journal-title":"Retina"},{"key":"R6-2-20210130","doi-asserted-by":"crossref","first-page":"85","DOI":"10.3928\/0191-3913-20060301-07","article-title":"Fundus fluorescein angiography in the screening for and management of retinopathy of prematurity.","volume":"43","author":"Ng","year":"2006","journal-title":"J Pediatr Ophthalmol Strabismus"},{"key":"R7-2-20210130","doi-asserted-by":"crossref","first-page":"233","DOI":"10.3928\/15428877-20070501-09","article-title":"Intravitreal bevacizumab in aggressive posterior retinopathy of prematurity.","volume":"38","author":"Travassos","year":"2007","journal-title":"Ophthalmic Surg Lasers Imaging"},{"key":"R8-2-20210130","doi-asserted-by":"crossref","first-page":"75","DOI":"10.4103\/0301-4738.29505","article-title":"Intravitreal bevacizumab (Avastin) for post laser anterior segment ischemia in aggressive posterior retinopathy of prematurity.","volume":"55","author":"Shah","year":"2007","journal-title":"Indian J Ophthalmol"},{"key":"R9-2-20210130","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1007\/s00417-007-0661-y","article-title":"Combination of laser photocoagulation and intravitreal bevacizumab (Avastin) for aggressive zone I retinopathy of prematurity.","volume":"245","author":"Chung","year":"2007","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"R10-2-20210130","doi-asserted-by":"crossref","first-page":"S13","DOI":"10.1097\/IAE.0b013e3181644ad2","article-title":"Off-label use of intravitreal bevacizumab (Avastin) for salvage treatment in progressive threshold retinopathy of prematurity.","volume":"28","author":"Lalwani","year":"2008","journal-title":"Retina"},{"key":"R11-2-20210130","doi-asserted-by":"crossref","first-page":"S19","DOI":"10.1097\/IAE.0b013e318159ec6b","article-title":"Antiangiogenic therapy with intravitreal bevacizumab for retinopathy of prematurity.","volume":"28","author":"Quiroz-Mercado","year":"2008","journal-title":"Retina"},{"key":"R12-2-20210130","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1097\/IAE.0b013e318177f934","article-title":"Intravitreal injection of bevacizumab (Avastin) for treatment of stage 3 retinopathy of prematurity in zone I or posterior zone II.","volume":"28","author":"Mintz-Hittner","year":"2008","journal-title":"Retina"},{"key":"R13-2-20210130","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1007\/s00417-008-0786-7","article-title":"Acute contraction of the proliferative membrane after an intravitreal injection of bevacizumab for advanced retinopathy of prematurity.","volume":"246","author":"Honda","year":"2008","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"R14-2-20210130","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1136\/bjo.2008.140657","article-title":"Efficacy of intravitreal injection of bevacizumab for severe retinopathy of prematurity: a pilot study.","volume":"92","author":"Kusaka","year":"2008","journal-title":"Br J Ophthalmol"},{"key":"R15-2-20210130","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.jaapos.2009.10.011","article-title":"Intravitreal bevacizumab as adjunctive treatment for retinopathy of prematurity.","volume":"14","author":"Law","year":"2010","journal-title":"J AAPOS"},{"key":"R16-2-20210130","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3928\/15428877-20100215-03","article-title":"Combination of laser photocoagulation and intravitreal bevacizumab in aggressive posterior retinopathy of prematurity.","volume":"9","author":"Altinsoy","year":"2010","journal-title":"Ophthalmic Surg Lasers Imaging"},{"key":"R17-2-20210130","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1007\/s00417-010-1375-0","article-title":"Effects of intravitreal bevacizumab and laser in retinopathy of prematurity therapy on the development of peripheral retinal vessels.","volume":"248","author":"Lee","year":"2010","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"R18-2-20210130","doi-asserted-by":"crossref","first-page":"S24","DOI":"10.1097\/IAE.0b013e3181ca1457","article-title":"Treatment of type 1 retinopathy of prematurity with intravitreal bevacizumab (Avastin).","volume":"30","author":"Dorta","year":"2010","journal-title":"Retina"},{"key":"R19-2-20210130","doi-asserted-by":"crossref","first-page":"S32","DOI":"10.1097\/IAE.0b013e3181ca146b","article-title":"Vitrectomy after intravitreal bevacizumab (Avastin) for retinal detachment in retinopathy of prematurity.","volume":"30","author":"Kychenthal","year":"2010","journal-title":"Retina"},{"key":"R20-2-20210130","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1056\/NEJMoa1007374","article-title":"Efficacy of intravitreal bevacizumab for stage 3 retinopathy of prematurity.","volume":"364","author":"Mintz-Hittner","year":"2011","journal-title":"N Engl J Med"},{"key":"R21-2-20210130","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/S1537-1891(03)00011-9","article-title":"Regulation of vascular permeability by vascular endothelial growth factors.","volume":"39","author":"Bates","year":"2002","journal-title":"Vascul Pharmacol"},{"key":"R22-2-20210130","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1016\/j.ophtha.2007.08.050","article-title":"Vitreous levels of stromal cell-derived factor 1 and vascular endothelial growth factor in patients with retinopathy of prematurity.","volume":"115","author":"Sonmez","year":"2008","journal-title":"Ophthalmology"},{"key":"R23-2-20210130","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1016\/j.ophtha.2008.12.023","article-title":"Vitreous levels of erythropoietin and vascular endothelial growth factor in eyes with retinopathy of prematurity.","volume":"116","author":"Sato","year":"2009","journal-title":"Ophthalmology"},{"key":"R24-2-20210130","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1001\/archopht.121.12.1684","article-title":"Revised indications for the treatment of retinopathy of prematurity. Results of the early treatment for retinopathy of prematurity randomized trial.","volume":"121","year":"2003","journal-title":"Arch Ophthalmol"},{"key":"R25-2-20210130","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1542\/peds.114.2.490","article-title":"The Early 4: Treatment for Retinopathy of Prematurity study: better outcomes, changing strategy.","volume":"114","author":"Phelps","year":"2004","journal-title":"Pediatrics"},{"key":"R26-2-20210130","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1016\/S0002-9440(10)65004-3","article-title":"Vascular endothelial growth and hepatocyte growth factor levels are differentially elevated in patients with advanced retinopathy of prematurity.","volume":"156","author":"Lashkari","year":"2000","journal-title":"Am Pathol"},{"key":"R27-2-20210130","first-page":"1217","article-title":"Vascularization of the human fetal retina: roles of vasculogenesis and angiogenesis.","volume":"41","author":"Hughes","year":"2000","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R28-2-20210130","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1097\/MOP.0b013e32832925f9","article-title":"Antivascular endothelial growth factor for retinopathy of prematurity.","volume":"21","author":"Mintz-Hittner","year":"2009","journal-title":"Curr Opinion Pediatr"},{"key":"R29-2-20210130","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1001\/archophthalmol.2010.145","article-title":"Fluorescein angiography of recurrent retinopathy of prematurity after initial intravitreous bevacizumab treatment.","volume":"128","author":"Hoang","year":"2010","journal-title":"Arch Ophthalmol"},{"key":"R30-2-20210130","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1001\/archophthalmol.2008.1","article-title":"Intravitreal bevacizumab as anti-vascular endothelial growth factor therapy for retinopathy of prematurity: a morphologic study.","volume":"126","author":"Kong","year":"2008","journal-title":"Arch Ophthalmol"},{"key":"R31-2-20210130","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1038\/eye.2009.156","article-title":"Paradoxical vascular-fibrotic reaction after intravitreal bevacizumab for retinopathy of prematurity.","volume":"24","author":"Zepeda-Romero","year":"2010","journal-title":"Eye"},{"key":"R32-2-20210130","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1016\/j.ajo.2009.05.031","article-title":"A systematic analysis of the off-label use of bevacizumab for severe retinopathy of prematurity.","volume":"148","author":"Micieli","year":"2009","journal-title":"Am J Ophthalmol"}],"container-title":["Retina"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00006982-201107000-00002","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T19:25:58Z","timestamp":1786044358000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00006982-201107000-00002"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,7]]},"references-count":32,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2011]]}},"URL":"https:\/\/doi.org\/10.1097\/iae.0b013e31820d4000","relation":{},"ISSN":["0275-004X"],"issn-type":[{"value":"0275-004X","type":"print"}],"subject":[],"published":{"date-parts":[[2011,7]]}}}